21 studies found for:    " October 17, 2007":" November 16, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
Conditions: HIV-1 Infections;   HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate (TDF);   Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF);   Drug: Placebo
2 Completed Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage
Conditions: HIV-1 Infection;   HIV Infection
Intervention: Drug: Efavirenz
3 Completed
Has Results
KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: Abacavir/lamivudine and efavirenz;   Drug: Tenofovir/Emtricitabine and efavirenz
4 Completed Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients
Conditions: Human Immunodeficiency Viruses;   Kidney Failure;   HIV Infections
Intervention:
5 Completed Motivation and Patch Treatment for HIV-Positive Smokers
Conditions: HIV Infections;   Smoking Cessation
Interventions: Behavioral: Standard Care;   Behavioral: Motivational Enhancement
6 Recruiting Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy
Condition: HIV Infections
Intervention: Drug: Cell Transfer
7 Completed Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence
Conditions: Opiate Dependence;   HIV Infections
Interventions: Behavioral: Enhanced Sexual Risk Management;   Behavioral: Standard Sexual Risk Management
8 Completed Rapid HIV Testing Program in the Emergency Department
Condition: HIV Infections
Intervention: Other: HIV test by oral swab
9 Completed Correlation Between Intestinal Parasites and Serum Level of Eosinophils and IgE in Individuals With HIV or AIDS
Condition: HIV Infections
Intervention:
10 Enrolling by invitation Utilization of HIV Clinical Services in Rural India
Conditions: HIV Infections;   Sexually Transmitted Infections
Intervention: Behavioral: HIV Testing and Care Services
11 Completed Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression
Condition: HIV Infections
Intervention: Drug: MK-0518 400mg twice a day
12 Completed Effect of HIV/STD Risk Reduction Program on South African Adolescents
Conditions: HIV Infections;   Sexually Transmitted Disease
Interventions: Behavioral: HIV/STD Risk-Reduction;   Behavioral: Health Promotion
13 Completed Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Vicriviroc;   Drug: Placebo
14 Completed A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African Adults
Condition: HIV Infections
Intervention: Other: Sutherlandia
15 Unknown  The Role of Diet Education and Nutritional Counselling in the Ongoing Care of People Living With HIV in Thailand
Condition: HIV Infections
Intervention: Behavioral: Nutrition Counselling
16 Completed Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients
Conditions: Hepatitis C, Chronic;   HIV Infections
Interventions: Drug: Pegylated interferon alfa-2a and Ribavirin;   Drug: Pegylated interferon alfa 2a and Ribavirin
17 Completed Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+
Conditions: Fibromyalgia;   HIV-1 Infection
Intervention: Drug: Duloxetine 60 mg, QD
18 Completed Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875)
Condition: HIV Infections
Interventions: Drug: Vicriviroc;   Drug: emtricitabine and tenofovir disoproxil fumarate
19 Completed Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea
Condition: HIV Associated Diarrhea
Interventions: Drug: Crofelemer 125 mg;   Drug: Crofelemer 250 mg;   Drug: Crofelemer 500 mg;   Drug: Placebo
20 Completed Evaluation and Monitoring of Patients With HIV Infectionn
Condition: HIV
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results
Indicates status has not been verified in more than two years